Skip to main content

Table 1 Pharmacodynamic effects of lesogaberan 30, 90, 120 and 240 mg relative to placebo (efficacy analysis set; n = 25)

From: Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study

Lesogaberan dose (mg)

Difference in geometric mean (%)

95% CI

p value*

Total number of reflux episodes†

30

-26.2

-12.7 to -37.6

0.0006

90

-37.0

-25.0 to -47.1

< 0.0001

120

-45.0

-35.5 to -53.1

< 0.0001

240

-52.8

-44.3 to -60.0

< 0.0001

Number of reflux episodes in upright position

30

-25.2

-11.1 to -37.1

0.0013

90

-38.4

-26.3 to -48.5

< 0.0001

120

-46.1

-36.5 to -54.2

< 0.0001

240

-50.7

-41.5 to -58.4

< 0.0001

Number of reflux episodes in supine position

30

-37.3

+2.0 to -61.5

0.0597

90

-12.3

+45.2 to -47.0

0.6042

120

-31.2

+9.3 to -56.7

0.1117

240

-69.1

-50.0 to -80.9

< 0.0001

Number of acid reflux episodes†

30

-34.7

+3.2 to -58.6

0.0677

90

-45.5

-12.3 to -66.1

0.0132

120

-57.9

-35.0 to -72.7

0.0002

240

-57.1

-32.5 to -72.7

0.0004

Number of weakly acid reflux episodes†

30

-28.3

-7.5 to -44.5

0.0113

90

-31.4

-10.7 to -47.4

0.0059

120

-44.5

-29.2 to -56.4

< 0.0001

240

-45.1

-29.3 to -57.3

< 0.0001

Number of pure liquid reflux episodes†

30

-27.9

+0.6 to -48.3

0.0540

90

-53.0

-33.6 to -66.7

< 0.0001

120

-44.1

-23.3 to -59.2

0.0005

240

-51.9

-33.1 to -65.4

< 0.0001

Number of mixed gas/liquid reflux episodes†

30

-25.0

-5.1 to -40.7

0.0175

90

-28.3

-8.4 to -43.8

0.0084

120

-42.5

-28.1 to -54.0

< 0.0001

240

-56.7

-45.4 to -65.7

< 0.0001

Proximal extent of reflux (cm)†

30

-39.1

-4.5 to -61.2

0.0312

90

-58.9

-34.4 to -74.2

0.0003

120

-66.3

-48.3 to -78.0

< 0.0001

240

-63.3

-42.8 to -76.5

< 0.0001

Proportion of time with esophageal pH < 4,%†

30

-69.8

-27.3 to -87.4

0.0083

90

-56.1

+9.0 to -82.3

0.0752

120

-65.7

-21.1 to -85.1

0.0126

240

-73.0

-35.6 to -88.6

0.0037

Proportion of time with intragastric pH < 4,%†

30

+40.4

+10.3 to +78.8

0.0066

90

+23.7

-3.8 to +58.9

0.0957

120

+3.6

-17.7 to +30.3

0.7625

240

+27.7

+0.6 to +62.1

0.0451

  1. CI, confidence interval.
  2. *Based on a mixed-effect analysis of variance model for log-transformed data.
  3. †In upright or supine position.